The filing is routine and unlikely to move the stock. Monitor the say-on-pay vote result on May 20; a significant negative vote could pressure management, but the Board's recommended FOR vote and lack of visible opposition suggest approval is likely.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 11 $451.83entry
- T+1 · 6mo ago +1.55%α +1.69% · $458.85
- T+5 · 6mo ago −2.45%α −2.37% · $440.74
- T+20 · 5mo ago +9.35%α +9.65% · $494.07
- T+60 · 3mo ago +27.33%α +23.21% · $575.33
Price Chart
How similar events traded
Executive Summary
Thermo Fisher Scientific filed supplemental proxy solicitation materials urging shareholders to vote FOR Proposal 2 (advisory say-on-pay) at the May 20, 2026 annual meeting. The letter from the Compensation Committee defends the 2025 CEO retention grant and highlights 2026 program changes, but provides no new material financial data.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for May 20, 2026
- Proposal 2 is an advisory vote on executive compensation (say-on-pay)
- 2025 CEO retention grant vests in May 2030, with shares delivered no earlier than 2033
- 2026 program changes include three-year PRSU design, adjusted EPS/relative TSR metrics, and elimination of one-time grants except in extraordinary circumstances
- Board recommends a FOR vote on Proposal 2
Financial Impact
No specific dollar amounts disclosed; compensation outcomes are described qualitatively.
Risk Factors
- A low say-on-pay approval rate could signal shareholder dissatisfaction and lead to further compensation changes.
- CEO retention grant and long vesting schedule may be viewed as too generous by some shareholders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0000097745-26-000095 |
| Document: 0000097745-26-000095-index-headers.html | 0000097745-26-000095 |
| Document: 0000097745-26-000095-index.html | 0000097745-26-000095 |
| Document: 0000097745-26-000095.txt | 0000097745-26-000095 |
Track record
21 reports on TMO
3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +29.04% at T+60 after the Jun 11, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $700.22 Now $691.33 −1.27% settles Feb 11
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $676.94 Now $691.33 +2.13% settles Feb 3
- Oct 30, 202617d ago 8-K Neutral 2/10 Entry $682.65 Now $691.33 +1.27% settles Jan 29
- Oct 28, 202619d ago 144 Neutral 2/10 Entry $709.18 Now $691.33 −2.52% settles Jan 27
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $694.02 Now $691.33 −0.39% settles Jan 19
- Oct 16, 20264w ago Institutional Cluster Neutral 3/10 Entry $690.00 Now $691.33 +0.19% settles Jan 13
- Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $608.54 Now $691.33 +13.60% settles Nov 27
- Aug 26, 202611w ago Insider Cluster Neutral 2/10 Entry $630.70 Now $691.33 +9.61% settles Nov 20
- Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $628.15 Now $691.33 +10.06% settles Nov 18
- Aug 18, 202613w ago Court Ruling Neutral 1/10 Entry $613.07 to $717.71 Now $691.33 +12.77% ▲ +17.07% +17.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers